Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aili (irinotecan) in recurrent or metastatic breast cancer
NCT02030678Phase 2Unknown
- Sponsor
- Liaoning Medical Center
- Start
- Sep 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinylestradiol + levonorgestrel in breast cancer, sponsored by Liaoning Medical Center. Status: unknown.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02030678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030678.